A 58-year-old woman has reached a full year living with a kidney transplanted from a genetically altered pig, setting a new benchmark for cross-species organ transplants, local television station WCVB reported.
The recipient, Molly Falco, underwent the procedure at Mass General Brigham in Boston. Her milestone marks the longest period that a genetically modified pig kidney has functioned inside a living human recipient, offering fresh optimism for thousands of Americans currently dependent on dialysis.
“I just thought, ‘What a cool thing to help the future in medicine,'” Falco said of her decision to participate in the procedure, as reported by WCVB. Celebrating the 12-month anniversary of the operation, she added, “I’m just amazed every day that it’s still working.”
Balancing Rejection and Infection Risks
Dr. Leo Riella, the medical director of Mass General Brigham’s kidney transplant program, commended Falco and other trial recipients for their courage. Riella called the patients “the true heroes” and described them as pioneers who put their own safety on the line to develop treatments for people suffering from severe renal disease.
One of the primary hurdles in xenotransplantation—transplanting animal organs into human bodies—is overcoming immune rejection. Patients require heavy doses of immunosuppressive medications to prevent their immune systems from attacking the foreign organ, but those same drugs significantly heighten the danger of infections.
Riella explained that treating Falco and prior recipients has helped clinicians refine their drug protocols. According to Riella, doctors have uncovered strategies regarding which medications should be continued long term and where dosages can safely be scaled back. Achieving that equilibrium remains essential to sustaining the viability of animal organs over years.
Building on Early Groundwork
Mass General Brigham has led several pioneering attempts in xenotransplantation. In 2024, the hospital carried out the world’s first transplant of a genetically engineered pig kidney in patient Rick Slayman. Slayman lived for 52 days before dying from an unrelated cardiac condition, according to hospital records cited by WCVB.
A second transplant took place in 2025 involving patient Tim Andrews. Andrews lived with his pig kidney for 271 days before doctors replaced the organ with a human kidney from a deceased donor. Falco was the fourth patient to undergo the procedure.
Since Falco received her kidney, two additional patients have undergone pig kidney transplants at Mass General Brigham. Both individuals are recovering well and have joined Falco and Andrews in an ongoing group chat for pig kidney recipients, Falco told WCVB.
Next Steps for Animal Organ Transplants
Transplant experts view genetically engineered pigs as a promising potential solution to the chronic shortage of human donor organs, The New York Times reported. If proven safe and resilient over prolonged periods, animal organs could provide a virtually unlimited supply of kidneys for patients with end-stage renal failure.
Riella said findings from an upcoming clinical study scheduled for next year will offer deeper insights into the long-term efficacy and safety of the procedure. Should those trial outcomes prove favorable, Riella estimated that an approved xenotransplant product could become available to humans within about five years, potentially providing an alternative to dialysis for select patient groups.
For Falco, the immediate reality remains a profound personal relief. “I got a transplant,” she told WCVB. “I was really fortunate. And I’m still alive, and I don’t have to do dialysis.”



